Analysis of Biopharmaceutical Lyophilizate Appearance and Structural State by X-Ray Microscopy (XRM) (CAT#: STEM-B-0424-CJ)

Introduction

The development of a lyophilized formulation and the corresponding freeze-drying process go hand in hand. An in-depth characterization of the freeze-dried powder during process development provides all relevant data require to optimize critical process parameters. Freeze-drying has advanced to the point where it is a common practice for biopharmaceuticals, including blood plasma and vaccines. Lyophilization is still a method of choice for preservation of the growing list of biopharmaceutical products.




Principle

X-ray microscopy is a complementary method to conventional visible light microscopy and electron imaging techniques like scanning and transmission electron microscopy (SEM/TEM). The critical advantage of XRM over optical microscopes is its 3D capability, which further allows for the visualization of bubbles, voids, and different materials. X-ray microscope emissions are narrowed into a tiny focal spot used to scan the sample.

Applications

Biopharmaceutica

Procedure

1. Sample preparation.
2. Place the sample on the instrument. By measuring the intensity distribution of X-rays that pass through the sample,
3. The 3D structure of the sample is visualized by rotating the X-ray transmission image obtained continuously by 180° on the computer (X-ray CT).

Materials

• Sample: Proteins, Peptides, Nucleic acids, Naturally-occurring compounds & more
• Equipment: X-Ray Microscopy (XRM)

We use cookies to understand how you use our site and to improve the overall user experience. This includes personalizing content and advertising. Read our Privacy Policy

Accept Cookies
×